Table 6.
Recipient characteristics according to retransplant outcomea
| Group I (n=208) | Group II (n=210) | Significance | |
|---|---|---|---|
| Age (yr) | 43.7±12.8 | 46.9±13.1 | P=0.01 |
| Sex (m/f) | 107/101 | 132/78 | P=0.018 |
| Time to ReTx (days) | 369±690 | 218±416 | P=0.007 |
| Preoperative bilirubin (mg/dl) | 15.6±12.6 | 20.0±14.9 | P=0.002 |
| Preoperative creatinine (mg/dl) | 2.1±1.5 | 2.7±1.9 | P=0.001 |
| Preoperative prothrombin time (s) | 17.5±7.3 | 17.6±5.9 | P=0.88 |
| UNOS 4 status (%) | 80.8 | 89.0 | P=0.018 |
| Preoperative mechanical ventilation (%) | 47.2 | 62.5 | P=0.002 |
| Primary immunosuppressant (%): | |||
| Tacrolimus | 60.1 | 58.4 | |
| Cyclosporine | 19.2 | 36.4 | |
| Tacrolimus rescue | 20.7 | 5.2 | P<0.0005 |
| Indication for ReTx (%): | |||
| Hepatitic | 4.8 | 11.9 | |
| PNF-ischemia | 39.4 | 40.5 | |
| Technical | 30.3 | 22.9 | |
| Acute rejection | 2.4 | 4.3 | |
| Chronic rejection | 21.2 | 11.9 | |
| Other | 1.9 | 8.5 | P=0.002 |
| Original diagnosis (%) | |||
| Alcoholic | 15.4 | 14.8 | |
| Autoimmune | 5.3 | 2.9 | |
| Cholestatic | 25.5 | 19.0 | |
| Cryptogenic | 12.5 | 9.0 | |
| FHF | 4.3 | 4.3 | |
| HCC-cholangio. | 3.4 | 7.6 | |
| Hepatitic | 25.0 | 30.5 | |
| Other malignancy | 0.5 | 1.9 | |
| Metabolic | 3.4 | 4.8 | |
| Other | 4.7 | 5.2 | P=0.24 |
a
Group I=grafts surviving more than one year; group II=grafts that failed within 1 year.